Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
Health First · Centro de Investigación Biomédica en Red de Enfermedades Respiratorias · +31 more institutions
Indexed incrossrefpubmed
Abstract
Executive summary of the Global Strategy for Prevention, Diagnosis and Management of COPD 2023: the latest evidence-based strategy document from the Global Initiative for Chronic Obstructive Lung Disease (GOLD) https://bit.ly/3KCaTGe
Citation impact
1,183
total citations
- FWCI
- 285.79
- Percentile
- 100%
- References
- 222
Citations per year
Authors
21- ÀAÀlvar AgustíCorresponding
Health First, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
- BRBartolomé R. Celli
Brigham and Women's Hospital, Harvard University, Health First
- GJGerard J. Criner
Temple University
- DHDavid Halpin
University of Exeter
- AAAntonio Anzueto
South Texas Veterans Health Care System
Topics & keywords
Topics
Keywords
- Medicine
- Obstructive lung disease
- COPD
- Lung disease
- Executive summary
- Pulmonary disease
- Gold standard (test)
- Intensive care medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- ATAmerican Thoracic Society
- PPfizer
- AAstraZeneca
- GGlaxoSmithKline
- SSanofi
- TPTeva Pharmaceutical Industries
- CFChiesi Farmaceutici
- CFCOPD Foundation
- CBCSL Behring
- SSunovion
- RPRegeneron Pharmaceuticals
- NINational Institutes of Health
- CICanadian Institutes of Health Research
- AIAgenzia Italiana del Farmaco, Ministero della Salute